Cargando…
Renal Recovery following Liposomal Amphotericin B-Induced Nephrotoxicity
BACKGROUND: Acute kidney injury (AKI) is a common complication of treatment with liposomal amphotericin B (LAmB). The trajectory of renal recovery after LAmB-associated AKI has not been well described, nor has effect of LAmB dose on recovery of renal function been explored. OBJECTIVE: Characterize t...
Autores principales: | Personett, Heather A., Kayhart, Bryce M., Barreto, Erin F., Tosh, Pritish, Dierkhising, Ross, Mara, Kristin, Leung, Nelson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369474/ https://www.ncbi.nlm.nih.gov/pubmed/30809394 http://dx.doi.org/10.1155/2019/8629891 |
Ejemplares similares
-
2109. Liposomal Amphotericin B-associated Nephrotoxicity in Obese and Non-obese Patients
por: Tritle, Brandon, et al.
Publicado: (2019) -
601. Characterizing Modifiable Risk Factors for Liposomal Amphotericin B (L-AMB) Nephrotoxicity
por: Bialick, Kate, et al.
Publicado: (2022) -
WCN23-0704 Liposomal amphotericin associated nephrotoxicity in patients with Mucormycosis: An epidemic in the midst of Pandemic
por: KISHAN, A., et al.
Publicado: (2023) -
Serum Peak Sulfamethoxazole Concentrations Demonstrate Difficulty in Achieving a Target Range: A Retrospective Cohort Study
por: Dao, Bao D., et al.
Publicado: (2014) -
Amphotericin-B-liposomal/antibacterials/immunosuppressants: Various infections, nephrotoxicity and off-label use: 4 case reports
Publicado: (2022)